Commentary: Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy

Bibliographic Details
Main Authors:	Javier Durán, Manuel Estrada
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-04-01
Series:	Frontiers in Pharmacology
Subjects:	bimagrumab ActRIIA/B receptors skeletal muscle anabolic steroids myostatin/activin
Online Access:	http://journal.frontiersin.org/article/10.3389/fphar.2018.00381/full

Internet